Welcome to our dedicated page for BlackRock SEC filings (Ticker: BLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BlackRock, Inc. filings document the regulatory record of an asset manager with NYSE-listed common stock and 3.750% notes due 2035. Form 8-K disclosures furnish earnings releases and Regulation FD materials, report results of operations, and record material agreements such as amendments to the company's revolving credit facility.
Proxy and governance filings cover board elections, director independence, executive compensation, pay-versus-performance data and shareholder voting matters. Other 8-K disclosures describe compensation arrangements linked to BlackRock's private markets investment funds, capital-structure information for registered securities, and governance actions affecting the board and senior executive incentive programs.
BlackRock, Inc. director Gordon Nixon reported receiving a grant of common stock as a nonemployee director. On 12/31/2025, he was awarded 34 shares of BlackRock common stock under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan.
The grant was based on a reference price of $1,070.34 per share, which was the closing price on December 31, 2025. Following this award, Nixon beneficially owns 5,309 shares of BlackRock common stock in direct ownership.
BlackRock, Inc. director equity filing: A BlackRock nonemployee director reported receiving a grant of 27 shares of BlackRock common stock on 12/31/2025 under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The award was recorded at a reference value of $1,070.34 per share, which was the stock’s closing price on that date, and the director did not pay cash for the shares. Following this grant, the director beneficially owns 844 BlackRock common shares directly and 142 shares indirectly through a family trust, showing both personal and trust-based ownership positions in the company.
BlackRock, Inc. director reports stock grant and updated holdings. A BlackRock nonemployee director received a grant of 33 shares of common stock on December 31, 2025, recorded at a reference price of $1,070.34 per share, under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The grant was reported as an acquisition at a price of $0 because it was an equity award rather than an open-market purchase.
Following this grant, the director now beneficially owns 479 shares of BlackRock common stock directly. Additional indirect holdings include 10 shares held by the director’s son, 5 shares held by The Murphy 2019 Descendants' Trust, and 53 shares held by The Murphy 2024 Family Trust, reflecting both personal and family-related ownership in the company.
BlackRock, Inc. reported that one of its directors received a grant of company common stock as part of a nonemployee director compensation plan. On 12/31/2025, the director was awarded 32 shares of BlackRock common stock at a price of $0, reflecting an equity grant rather than an open-market purchase. After this grant, the director beneficially owned 2,166 shares directly and 1,715 shares indirectly through a family trust.
The shares were granted under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan and were valued using a reference price of $1,070.34 per share, which was the closing price of BlackRock stock on December 31, 2025. This filing documents routine equity-based compensation for a nonemployee director of BlackRock (NYSE: BLK).
BlackRock, Inc. director Fabrizio Freda reported a year-end stock award in the company’s common stock. On 12/31/2025, he acquired 18 shares of BlackRock common stock at a price of $0, reflecting a grant to a nonemployee director under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The grant was calculated using a reference price of $1,070.34 per share, which was the closing price on December 31, 2025. Following this award, he beneficially owns 3,548 BlackRock shares in direct ownership.
BlackRock, Inc. director William E. Ford reported a stock grant of company shares. On December 31, 2025, he received 34 shares of common stock, reported at a transaction price of $0 as they were awarded, not purchased. The award was granted under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan and was valued based on a $1,070.34 per share closing price on that date.
Following this grant, Ford beneficially owned 16,420 shares of BlackRock common stock in direct ownership, reflecting his ongoing equity stake as a nonemployee director.
BlackRock, Inc. director Pamela Daley reported receiving a grant of common stock as equity compensation. On December 31, 2025, she acquired 36 shares of BlackRock common stock at a price of $0 on the Form 4 (reflecting a non-cash award). After this grant, she beneficially owned 6,219 shares in total on a direct basis.
The shares were granted to her as a nonemployee director under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan, using a reference price of $1,070.34 per share, which was the stock’s closing price on December 31, 2025.
BlackRock, Inc. director reports stock gift
A BlackRock, Inc. director filed a Form 4 disclosing a gift of 28,550 shares of BlackRock common stock on 12/02/2025, coded as a disposition by gift at a price of $0. After this transaction, the director directly beneficially owns 1,338,407 shares of BlackRock common stock.
In addition to the directly held shares, the filing reports indirect ownership of 455,652 shares through Ogunlesi Investment Partners LLC, 101 shares through the Ogunlesi 2011 Investment Trust, and 317 shares through Raynham I LLC.
BlackRock, Inc. reported an insider share sale by its CFO and Senior Managing Director. On 12/01/2025, the reporting person sold 1,258 shares of BlackRock common stock at a price of $1,043.38 per share, recorded as a disposition of securities.
After this transaction, the reporting person beneficially owned 6,209.4148 shares of BlackRock common stock. This figure includes both common stock and restricted stock units that will vest over a period of 1 to 3 years, with each restricted stock unit payable in an equal number of shares of common stock.
A holder of common stock in the issuer has filed a notice under Rule 144 to sell 1,258 shares through Merrill Lynch, Pierce, Fenner & Smith Inc. on the NYSE, with an approximate sale date of 12/01/2025. The filing lists an aggregate market value of 1,311,263.72 for these shares and notes that there were 155,150,909 shares of the same class outstanding at the time referenced. The shares to be sold were originally acquired from the issuer on 01/31/2021 through a vesting transaction, indicating they likely stem from an equity award rather than an open-market purchase.